Press Releases

Poseida Therapeutics to Participate in SternIR Virtual Corporate Access Event

January 4, 2021

Poseida Therapeutics Added to NASDAQ Biotechnology Index

December 18, 2020

Poseida Therapeutics Appoints Luke Corning to Board of Directors

December 17, 2020

Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting

December 5, 2020

Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020

November 12, 2020

Poseida Therapeutics Announces Clinical Hold Lifted on Phase I Autologous CAR-T Study in Prostate Cancer

November 2, 2020

Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19

October 21, 2020

Poseida Therapeutics Added to Membership of US Small-Cap Russell 2000® Index

September 18, 2020

Poseida Therapeutics to Present CAR-T Manufacturing Process Optimization Data at CAR-TCR Digital Week 2020

September 16, 2020

Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020

August 20, 2020